Review



cd133 antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc cd133 antibody
    Cd133 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pmc13018870-6-0-3?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    cd133 antibody - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    95
    Miltenyi Biotec cd133/1 antibody, anti-human
    Cd133/1 Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/miltenyi+biotec___130-108-062?v=Miltenyi+Biotec
    Average 95 stars, based on 1 article reviews
    cd133/1 antibody, anti-human - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    Wuhan Sanying Biotechnology cd133 antibody
    Cd133 Antibody, supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pmc13195406-49-9-11?v=Wuhan+Sanying+Biotechnology
    Average 86 stars, based on 1 article reviews
    cd133 antibody - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec pe vio770 a
    Pe Vio770 A, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pmc13114382-56-2-6?v=Miltenyi+Biotec
    Average 94 stars, based on 1 article reviews
    pe vio770 a - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec mouse cd133 1 igg1κ ac133 pe miltenyi biotec
    Mouse Cd133 1 Igg1κ Ac133 Pe Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pm41991735-193-5-10?v=Miltenyi+Biotec
    Average 95 stars, based on 1 article reviews
    mouse cd133 1 igg1κ ac133 pe miltenyi biotec - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc cd133 antibody
    Cd133 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pmc13018870-6-0-3?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    cd133 antibody - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec cd133
    Cd133, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pm41991735-145-5-7?v=Miltenyi+Biotec
    Average 95 stars, based on 1 article reviews
    cd133 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec mouse cd133 1 igg1κ ac133
    CD133 and CXCR4 are overexpressed in PDAC. ( A ) Box plots represent relative mRNA expression for the gene signatures PROM1, CXCR4 or PROM1 and CXCR4 in normal tissue compared to PDAC tumor tissue (TCGA and GTEx database, GEPIA). ( B ) Protein–protein interactions of PROM1 (CD133) and CXCR4 with relevant factors involved in metastasis (green) and CSCs (red) (STRING). ( C ) Screening for percent CD133 + cells and ( D ) CD133 + CXCR4 + found in adherent cell culture of indicated cell lines. ( E ) Experimental scheme to evaluate CD133 and CXCR4 surface expression to identify patient derived xenografts (PDX) or patient derived organoids (PDO) crosstalk with pancreatic stellate cells (PSCs) at the protein level. ( F ) FACS analysis performed on Panc354 and MetPO1 when exposed to no conditioned media (grey), conditioned media from non—primed PSCs (blue) or conditioned media from primed PSCs (pink) for CD133 + cells, CXCR4 + cells <t>and</t> <t>CD133</t> + CXCR4 + cells represented as fold change against no conditioned media. ( G ) Representative cytometry blots. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.
    Mouse Cd133 1 Igg1κ Ac133, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pmc13087252-52-0-7?v=Miltenyi+Biotec
    Average 95 stars, based on 1 article reviews
    mouse cd133 1 igg1κ ac133 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    93
    R&D Systems human cd133 apc conjugated antibody
    CD133 and CXCR4 are overexpressed in PDAC. ( A ) Box plots represent relative mRNA expression for the gene signatures PROM1, CXCR4 or PROM1 and CXCR4 in normal tissue compared to PDAC tumor tissue (TCGA and GTEx database, GEPIA). ( B ) Protein–protein interactions of PROM1 (CD133) and CXCR4 with relevant factors involved in metastasis (green) and CSCs (red) (STRING). ( C ) Screening for percent CD133 + cells and ( D ) CD133 + CXCR4 + found in adherent cell culture of indicated cell lines. ( E ) Experimental scheme to evaluate CD133 and CXCR4 surface expression to identify patient derived xenografts (PDX) or patient derived organoids (PDO) crosstalk with pancreatic stellate cells (PSCs) at the protein level. ( F ) FACS analysis performed on Panc354 and MetPO1 when exposed to no conditioned media (grey), conditioned media from non—primed PSCs (blue) or conditioned media from primed PSCs (pink) for CD133 + cells, CXCR4 + cells <t>and</t> <t>CD133</t> + CXCR4 + cells represented as fold change against no conditioned media. ( G ) Representative cytometry blots. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.
    Human Cd133 Apc Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pm41977417-214-25-33?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    human cd133 apc conjugated antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals 16518 claudin 1 d5h1d
    CD133 and CXCR4 are overexpressed in PDAC. ( A ) Box plots represent relative mRNA expression for the gene signatures PROM1, CXCR4 or PROM1 and CXCR4 in normal tissue compared to PDAC tumor tissue (TCGA and GTEx database, GEPIA). ( B ) Protein–protein interactions of PROM1 (CD133) and CXCR4 with relevant factors involved in metastasis (green) and CSCs (red) (STRING). ( C ) Screening for percent CD133 + cells and ( D ) CD133 + CXCR4 + found in adherent cell culture of indicated cell lines. ( E ) Experimental scheme to evaluate CD133 and CXCR4 surface expression to identify patient derived xenografts (PDX) or patient derived organoids (PDO) crosstalk with pancreatic stellate cells (PSCs) at the protein level. ( F ) FACS analysis performed on Panc354 and MetPO1 when exposed to no conditioned media (grey), conditioned media from non—primed PSCs (blue) or conditioned media from primed PSCs (pink) for CD133 + cells, CXCR4 + cells <t>and</t> <t>CD133</t> + CXCR4 + cells represented as fold change against no conditioned media. ( G ) Representative cytometry blots. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.
    16518 Claudin 1 D5h1d, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+antibody/pm41968320-118-47-42?v=Novus+Biologicals
    Average 93 stars, based on 1 article reviews
    16518 claudin 1 d5h1d - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    CD133 and CXCR4 are overexpressed in PDAC. ( A ) Box plots represent relative mRNA expression for the gene signatures PROM1, CXCR4 or PROM1 and CXCR4 in normal tissue compared to PDAC tumor tissue (TCGA and GTEx database, GEPIA). ( B ) Protein–protein interactions of PROM1 (CD133) and CXCR4 with relevant factors involved in metastasis (green) and CSCs (red) (STRING). ( C ) Screening for percent CD133 + cells and ( D ) CD133 + CXCR4 + found in adherent cell culture of indicated cell lines. ( E ) Experimental scheme to evaluate CD133 and CXCR4 surface expression to identify patient derived xenografts (PDX) or patient derived organoids (PDO) crosstalk with pancreatic stellate cells (PSCs) at the protein level. ( F ) FACS analysis performed on Panc354 and MetPO1 when exposed to no conditioned media (grey), conditioned media from non—primed PSCs (blue) or conditioned media from primed PSCs (pink) for CD133 + cells, CXCR4 + cells and CD133 + CXCR4 + cells represented as fold change against no conditioned media. ( G ) Representative cytometry blots. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.

    Journal: Scientific Reports

    Article Title: A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma

    doi: 10.1038/s41598-026-48584-2

    Figure Lengend Snippet: CD133 and CXCR4 are overexpressed in PDAC. ( A ) Box plots represent relative mRNA expression for the gene signatures PROM1, CXCR4 or PROM1 and CXCR4 in normal tissue compared to PDAC tumor tissue (TCGA and GTEx database, GEPIA). ( B ) Protein–protein interactions of PROM1 (CD133) and CXCR4 with relevant factors involved in metastasis (green) and CSCs (red) (STRING). ( C ) Screening for percent CD133 + cells and ( D ) CD133 + CXCR4 + found in adherent cell culture of indicated cell lines. ( E ) Experimental scheme to evaluate CD133 and CXCR4 surface expression to identify patient derived xenografts (PDX) or patient derived organoids (PDO) crosstalk with pancreatic stellate cells (PSCs) at the protein level. ( F ) FACS analysis performed on Panc354 and MetPO1 when exposed to no conditioned media (grey), conditioned media from non—primed PSCs (blue) or conditioned media from primed PSCs (pink) for CD133 + cells, CXCR4 + cells and CD133 + CXCR4 + cells represented as fold change against no conditioned media. ( G ) Representative cytometry blots. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.

    Article Snippet: Mouse CD133/1 IgG1κ (AC133) , PE , Miltenyi Biotec , 130-113-108.

    Techniques: Expressing, Protein-Protein interactions, Cell Culture, Derivative Assay, Cytometry, Standard Deviation

    BMI1 downstream CXCL12–CXCR4 regulates EMT and stemness. ( A ) Protein–protein interactions of CXCL12 and CXCR4 with relevant factors involved in metastasis (red), stemness (purple), sonic hedgehog signaling (blue), AKT signaling (grey) and NFκB pathway (yellow) (STRING). ( B ) BMI1 gene expression analysis and western blot analysis. GAPDH was used as a loading control. Intensity ratios (IR) calculated against control lane using ImageJ. Cropped blot for clarity. ( C ) Gene expression analysis with genes involved in EMT using qRT-PCR. ( D ) Immunofluorescence quantifications and representative micrographs for indicated cell lines with white arrowheads marking mesenchymal structures of actin filaments stained with Phalloidin (pink) and nucleus stained with DAPI (blue). ( E ) Migration assays towards serum containing media. ( F ) Experimental scheme to evaluate CD133 and CXCR4 surface expression using flow cytometry for Panc354 and MetPO1 (sh_ SCR , sh1_ BMI1 and sh2_ BMI1 ) with (or without) CXCL12. ( G ) Flow cytometry analysis of CD133 + cells and CD133 + CXCR4 + cells in MetPO1 (sh_ SCR , sh1_ BMI1 and sh2_ BMI1 ) treated with (or without) CXCL12. ( H ) Representative cytometry plots for MetPO1 cell line. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.

    Journal: Scientific Reports

    Article Title: A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma

    doi: 10.1038/s41598-026-48584-2

    Figure Lengend Snippet: BMI1 downstream CXCL12–CXCR4 regulates EMT and stemness. ( A ) Protein–protein interactions of CXCL12 and CXCR4 with relevant factors involved in metastasis (red), stemness (purple), sonic hedgehog signaling (blue), AKT signaling (grey) and NFκB pathway (yellow) (STRING). ( B ) BMI1 gene expression analysis and western blot analysis. GAPDH was used as a loading control. Intensity ratios (IR) calculated against control lane using ImageJ. Cropped blot for clarity. ( C ) Gene expression analysis with genes involved in EMT using qRT-PCR. ( D ) Immunofluorescence quantifications and representative micrographs for indicated cell lines with white arrowheads marking mesenchymal structures of actin filaments stained with Phalloidin (pink) and nucleus stained with DAPI (blue). ( E ) Migration assays towards serum containing media. ( F ) Experimental scheme to evaluate CD133 and CXCR4 surface expression using flow cytometry for Panc354 and MetPO1 (sh_ SCR , sh1_ BMI1 and sh2_ BMI1 ) with (or without) CXCL12. ( G ) Flow cytometry analysis of CD133 + cells and CD133 + CXCR4 + cells in MetPO1 (sh_ SCR , sh1_ BMI1 and sh2_ BMI1 ) treated with (or without) CXCL12. ( H ) Representative cytometry plots for MetPO1 cell line. Error bars represent the standard deviation. n = 3 for all experiments unless otherwise depicted in the datasets. * p < 0.05, ns = not significant.

    Article Snippet: Mouse CD133/1 IgG1κ (AC133) , PE , Miltenyi Biotec , 130-113-108.

    Techniques: Protein-Protein interactions, Gene Expression, Western Blot, Control, Quantitative RT-PCR, Immunofluorescence, Staining, Migration, Expressing, Flow Cytometry, Cytometry, Standard Deviation